Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
59.8M
-
Shares change
-
+1.86M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$43.7M
-
Put/Call ratio
-
1.21
-
Number of buys
-
117
-
Number of sells
-
-93
-
Price
-
$32.86
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2024
264 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2024.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.8M shares
.
Largest 10 shareholders include FARALLON CAPITAL MANAGEMENT LLC (5.67M shares), VANGUARD GROUP INC (5.63M shares), BlackRock, Inc. (5.02M shares), Bellevue Group AG (3.52M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.42M shares), ARMISTICE CAPITAL, LLC (2.26M shares), STATE STREET CORP (2.15M shares), Erste Asset Management GmbH (2.01M shares), MACQUARIE GROUP LTD (1.68M shares), and Jefferies Financial Group Inc. (1.5M shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.